Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices (Revision: v3.4.1 and a government funding status notice) were removed, indicating a UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T15:45:39.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision v3.4.1 was added and v3.4.0 removed, and a site-wide notice regarding government funding and NIH operations was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:52:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    UI/formatting updates on the history page include a glossary toggle, color-coded change indicators (green for additions, red for deletions), and updated revision metadata to v3.4.0. The capitalization of the No FEAR Act label was adjusted.
    Difference
    0.5%
    Check dated 2026-01-28T06:36:31.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4, indicating a minor site update with no changes to study data or history details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:43:13.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page history shows an addition of Revision: v3.3.3 and deletions of HHS Vulnerability Disclosure and Revision: v3.3.2, indicating administrative updates to the site’s footer and history entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:32:31.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.2.0 to v3.3.2. No changes to study data, layouts, or navigation were observed.
    Difference
    0.1%
    Check dated 2025-11-24T17:41:04.000Z thumbnail image

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.